MedPath
HSA Approval

ASMOL SYRUP 2 mg/5 ml

SIN02461P

ASMOL SYRUP 2 mg/5 ml

ASMOL SYRUP 2 mg/5 ml

February 27, 1989

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence HolderSUNWARD PHARMACEUTICAL PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

R03CC02

salbutamol

Manufacturer Information

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PTE LTD

Active Ingredients

SALBUTAMOL SULPHATE EQV SALBUTAMOL

2 mg/5 ml

Salbutamol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ASMOL SYRUP 2 mg/5 ml - HSA Approval | MedPath